GSK PLC ADR
2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30
Holding superinvestors
| Superinvestor | Shares | Value | Weight | Change |
|---|---|---|---|---|
| Dodge & Cox Funds | 43,183,117 | $2.08B | 1.1% | Reduced |
| Kahn Brothers Group | 113,552 | $5.47M | 0.9% | Reduced |
| Hillman Capital Management | 91,962 | $4.43M | 3.3% | Reduced |
| Tweedy Browne | 77,439 | $3.73M | 0.3% | Reduced |
| Pzena Investment Management | 28,964 | $1.395M | 0.0% | Added |
By quarter
| Quarter | Holders | Total value |
|---|---|---|
| 2022-06-30 | 1 | $11.24M |
| 2022-09-30 | 5 | $1.743B |
| 2022-12-31 | 6 | $2.312B |
| 2023-03-31 | 6 | $2.511B |
| 2023-06-30 | 5 | $2.514B |
| 2023-09-30 | 5 | $2.55B |
| 2023-12-31 | 5 | $2.603B |
| 2024-03-31 | 4 | $2.999B |
| 2024-06-30 | 4 | $2.672B |
| 2024-09-30 | 4 | $2.833B |
| 2024-12-31 | 4 | $2.362B |
| 2025-03-31 | 4 | $3.1B |
| 2025-06-30 | 6 | $3.102B |
| 2025-09-30 | 6 | $3.456B |
| 2025-12-31 | 6 | $3.381B |
| 2026-03-31 | 6 | $3.258B |
| 2026-06-30 | 6 | $2.546B |
| 2026-09-30 | 5 | $2.095B |